Ab0302 discontinuation Rate and Predictors of Jaki Discontinuation in a Real Life Cohort: Results From a Multicentric Italian Study on 864 Patients With Ra
Abstract:BackgroundThe recent EULAR recommendations [1,2] suggest using JAK-inhibitors (JAKis) for treating RA patients. These drugs include both selective (upadactinib and filgotinib) and unselective (tofacitinib and baricitinib) JAKis.ObjectivesTo describe JAKis’ discontinuation rate and to determine predictors of JAKIs’ discontinuation in a real life setting.MethodsAll patients with RA treated with JAKis were prospectively followed up for at least 12 months in this multicentric study carried out on 23 Italian centre… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.